Trial
NCT01713803
Evaluation of BEMA® Buprenorphine NX for Buprenorphine Induction of Opioid Dependent Subjects
Phase IIIWITHDRAWNREGULATORYConfidence: MEDIUM
Sponsor
BioDelivery Sciences International
Collaborators
—
Condition
Opioid Dependence
Intervention
Buprenorphine and naloxone
Why stopped
FDA did not require a clinical trial for indication.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-05-04